Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Neurocrine Biosciences
Biotech
Takeda taps Julie Kim as new CEO—Chutes & Ladders
Takeda taps Kim as new CEO. Kailera goes commercial with Lilly vet. Roche adds technology officer to executive team.
Darren Incorvaia
,
Zoey Becker
Jan 31, 2025 8:30am
Takeda regains home rights to depression drug from Neurocrine
Jan 28, 2025 4:16am
Neurocrine, Idorsia part ways 2 years after double phase 2 fails
Oct 29, 2024 7:15am
Neurocrine's bid to save schizophrenia prospect fails
Sep 13, 2024 7:30am
Neurocrine's KarXT rival hits in phase 2—but only at low dose
Aug 28, 2024 7:53am
Roche, Vir, Neurocrine & more—Chutes & Ladders
May 31, 2024 8:30am